Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Yield10 Bioscience
AddedFeb 19, 2024
UpdatedJun 18, 2026
Yield10 Bioscience

Yield10 Bioscience

Public

Yield10 Bioscience, an American firm, innovates disruptive agri-bioscience tech for significant crop yield improvements.

HQ
Woburn, MA, US
Founded
1992
Overview
Compare
Fundraising
Employees
Website

Yield10 Bioscience is an American agricultural bioscience company focused on developing disruptive technologies to significantly improve crop yields for food and feed crops, thereby enhancing global food security. The company specializes in creating superior camelina varieties to produce PHA bioplastics, low-carbon index feedstocks for renewable diesel biofuel, and land-based Omega-DHA and EPA oils. Their market focus includes growers, biofuel, and food businesses in the United States.

Yield10 Bioscience has made notable strides in commercializing its proprietary non-commodity camelina varieties. These innovations target markets such as camelina oil for low-carbon biofuels, camelina meal for animal feed, and PHAs produced in camelina seeds. The company's advancements contribute to sustainability and offer significant potential for reducing carbon footprints in various industries.

Yield10 Bioscience - Quick Facts

When was Yield10 Bioscience founded?

Yield10 Bioscience was founded in 1992.

Where is Yield10 Bioscience's headquarters located?

Yield10 Bioscience's headquarters is located in Woburn, MA, US.

When was Yield10 Bioscience's last funding round?

Yield10 Bioscience's most recent funding round was for $3.7M (USD) in August 2023.

How much has Yield10 Bioscience raised to-date?

As of Aug 11, 2023, Yield10 Bioscience has raised a total of $125.4M (USD).

How many employees does Yield10 Bioscience have?

Yield10 Bioscience has 29 employees as of Feb 6, 2024.

Yield10 Bioscience - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Crop Yield
Tags
  • AgTech
NAICS
  • 320000Manufacturing
  • 325300Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing
  • 325320Pesticide and Other Agricultural Chemical Manufacturing
  • 325000Chemical Manufacturing
SIC
  • 100Agricultural Production-crops
ISIC
  • 2013Manufacture of plastics and synthetic rubber in primary forms
Show 14 more industry codes
NAICS
  • 325200Resin, Synthetic Rubber, and Artificial and Synthetic Fibers and Filaments Manufacturing
  • 325210Resin and Synthetic Rubber Manufacturing
  • 325211Plastics Material and Resin Manufacturing
SIC
  • 1000Metal Mining
  • 2820Plastics Materials And Synthetic Resins, Synthetic Rubber, Cellulosic Manmade Fibers
  • 2821Plastics Materials, Synthetic Resins, And Nonvulcanizable Elastomers
  • 2870Agricultural Chemicals
  • 2879Pesticides And Agricultural Chemicals, Not Elsewhere Classified
  • 2890Miscellaneous Chemical Products
  • 2899Chemicals And Chemical Preparations, Not Elsewhere Classified
  • 3000Rubber And Miscellaneous Plastics Products
  • 3080Miscellaneous Plastics Products
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation